Challenges remain in the process to demonstrate the efficacy of acupuncture, despite the emergence of evidence-based medicine . A more applicable and innovative research methodology that can reflect the effectiveness of acupuncture is needed, for improving future research into this integrative intervention, and CT’s based on OPC concept are worth developing.
To date, the gold standard for evaluation of a treatment is RCT with high methodological quality and high power, which can provides the highest level of scientific evidence. It would be interesting to add OPC methodology in the recommendations of grades, especially when blinding is difficult. A combined approach using a multidisciplinary team incorporating considerations of efficacy, effectiveness and qualitative measures, will strengthen the evidence base for acupuncture .
The OPC is a criteria based on published literature (meta-analyzes) and/or reliable registries OPC may be considered when disease natural history is well known, patient population well described, in case of extensive experience with acupuncture treatment, stable and well known standard of care, no significant new questions of safety and effectiveness, and expectation of significant positive treatment effect. The OPC use offers several advantages over randomized clinical trials: smaller sample size, standardized comparator for future trials, reduced cost, shortened time to completion, simpler logistic.
However the determination of an OPC is not a simple task. It requires rigorous and scientifically valid methodologies. An OPC should be established by a multidisciplinary team of Traditional Chinese Medicine (TCM) practitioners, and Western physicians in cooperation with statisticians.
OPC concept could represent an acceptable and scientifically valid alternative to determine effectiveness of acupuncture. Acupuncturists should consider this methodology when randomization and double-blindness are problematic.
CAM: complementary and alternative medicine
CI: confidence interval
CT: clinical trial
FDA: Food and Drug Administration
ICMART: International Council of Medical Acupuncture and Related Technique
OPC: objective performance criteria
RCT: randomized control trial
RR: relative risk
SMD: standardized mean difference
TCM: Traditional Chinese Medicine
US: the United States
The authors declare that they have no competing interests.
- Anne-Sophie Piau, Sophie Broquet (Jeanne de Flandre Hospital, Lille, France): investigators of the trial on perineal relaxation during fetal expulsion.
- Caroline Mollet, Sandra Dumortier (Paul Gellé Hospital Maternity, Roubaix, France): investigators of the trial on the third stage of labor.
- Prof Véronique Houfflin-Debarge, Hélène Montaigne, MD: Lille 2 University, France.
- 1.Sapirstein W. The conduct of clinical trials: a Food and Drug Agency perspective. ASAIO J. 2000;46(1):29-30.PubMed
- Faris O, Chen E, Berman M, Moynahan M, Zuckerman B.A US Food and Drug Administration perspective on cardiac resynchronization and ventricular assist device trials. Congest Heart Fail. 2005;11(4):207-211. PubMed
- Dorrothy B. Standardized Objective Performance Criteria and Control Datasets - How the FDA is working to determine the potential role for these criteria in peripheral device regulation, and how they are best established. (April 2006): Available from URL:http://bmctoday.net/evtoday/2006/04/article.asp?f=EVT0406_FDA.html
- Chen E, Sapirstein W, Ahn C, Swain J, Zuckermn B. FDA Perspective on Clinical Trial Design for Cardiovascular Devices. Ann Thorac Surg., 2006;82:773-5.PubMed
5 Grunkemeier GL, Ji R, Starr A. Prosthetic heart valves: Objective Performance Criteria versus randomized clinical trial. Ann Thorac Surg. 2006;82(3):776-780. PubMed
- Conte MS, Geraghty PJ, Bradbury AW, Hevelone ND, Lipsitz SR, Moneta GL, Nehler MR, Powell RJ, Sidawy AN. Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia.J Vasc Surg. 2009;50(6):1462-73. PubMed
- Kumar A, Brooks SS, Cavanaugh K, Zuckerman B. FDA perspective on objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg. 2009 Dec;50(6):1474-76.PubMed
- Parides MK, Moskowitz AJ, Ascheim DD, Rose EA, Gelijns AC. Progress versus precision challenges in clinical trial design for left ventricular assist devices,Ann Thorac Surg. 2006;82:1140-46.PubMed
- Rocha-Singh KJ, Jaff MR, Cratree TR, Bloch DA, Ansel G, VIVA Physicians, Inc.Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease. Catheter Cardiovasc Interv. 2007;69(6):910-9. PubMed
- Brignol TN, Verta P. Can OPC (Objective Performance Criteria) used in FDA approval for medical devices represent an acceptable and scientifically valid alternative to show efficacy in clinical trials in Acupuncture? XIII ICMART World Congress on Medical Acupuncture – The Hague (Netherland).13-15 May 2011. Abstract 22 (p 31). Available from URL: http://www.icmart.org/files/icmart_congress_2011_abstract.pdf
- Brignol TN, Verta P. Une méthodologie basée sur l’OPC (Objective performance criteria) est-elle valable pour prouver l’efficacité de l’acupuncture ?Acupuncture & Moxibustion, 2011;10(3): 204-206. Available from URL:https://www.meridiens.org/mrd/IMG/pdf/Acupuncture_et_Moxibustion__Brignol-Verta_vol10_no3_2011.pdf
- Mårtensson L, Kvist L, Hermansson E. A national survey of how acupuncture is currently used in midwifery care at Swedish maternity units. Midwifery. 2011;27(1):87-92. PubMed
- Münstedt K, Thienel J, Hrogovic I, Hackethal A, Kalder M, Misselwitz B. Use of acupuncture and other CAM methods in obstetrics: an analysis of 409,413 deliveries from Hesse, Germany. J Altern Complement Med. 2011;17(5):421-26.PubMed
- Stéphan JM.DIU d’Acupuncture Obstétricale : tableaux d’une exposition,Acupuncture & Moxibustion, 2013;12(2): 147-151. Available from URL: https://www.meridiens.org/acuMoxi/douzedeux/STEPHAN-DIU_perinee.pdf.
- Stéphan JM. DIU d’Acupuncture Obstétricale : tableaux d’une exposition. Délivrance et cholestase gravidique. Acupuncture & Moxibustion. 2014;13(3):213-217.Available from URL: https://www.meridiens.org/acuMoxi/treizetrois/STEPHAN-DIU13-3.pdf.
- Gouan L, Yiliang Z. Clinical report about controlling postpartum hemorrhage with electric stimulation at acupuncture points. in selections from article abstracts on acupuncture and moxibustion, Beijing 1987:134.
- Xu L, Liang-fang S, Jun-yan L, Wei-hong Z. Needling Hegu to accelerate the second labor stage, International Journal of Clinical Acupuncture. 1995;6(1):101-103.
- Bader W, Ast S, Hatzmann W. Die Bedeutung der Akupunktur in der Plazentarperiode. Dt. Ztschr. f. Akupunktur. 2000;4:264-268.
- Cotter AM, Ness A, Tolosa JE. Prophylactic oxytocin for the third stage of labour. Cochrane Database Syst Rev 2001;4:CD001808.PubMed
- Westhoff G, Cotter AM, Tolosa JE. Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. Cochrane Database Syst Rev. 2013 Oct 30;10:CD001808.
- Begley CM, Gyte GM, Devane D, McGuire W, Weeks A. Active versus expectant management for women in the third stage of labour. Cochrane Database Syst Rev. 2015 Mar 2;3:CD007412. doi: 10.1002/14651858.CD007412.pub4.PubMed
- Benedetti F, Maggi G, Lopiano L et al. Open versus hidden medical treatments: the patient’s knowledge about a therapy affects the therapy outcome. Prev Treat. 2003; doi: 10.1037/1522-37188.8.131.52a.
- Lund I, Lundeberg T. Are minimal, superficial or sham acupuncture procedures acceptable as inert placebo controls? Acupunct Med. 2006;24(1):13-5.PubMed
- LindeK,Niemann K, Schneider A, Meissner K. How large are the nonspecific effects of acupuncture? A meta-analysis of randomized controlled trials. BMC Med. 2010;8:75. PubMed
- Godwin J. Rising to the challenges of evidence-based medicine: a way forward for acupuncture. J Altern Comlement Med.2014 Nov;20(11):805-9. doi: 10.1089/acm.2014.0213. Epub 2014 Sep 19.PubMed
- Langevin HM, Wayne PM, Macpherson H, Schnyer R, Milley RM, Napadow V, Lao L, Park J, Harris RE, Cohen M, Sherman KJ, Haramati A, Hammerschlag R. Paradoxes in acupuncture research: strategies for moving forward. Evid Based Complement Alternat Med.2011;2011:180805. doi: 10.1155/2011/180805. Epub 2010 Oct 11.PubMed
To cite: Brignol TN, Stéphan JM, Verta A. Acupuncture clinical trials without a control group in Obstetrics : a French experience alternative approach using OPC (objective performance criteria). Acupuncture & Moxibustion (online). Feb 2016. Available from: URL: https://meridiens.org/acuMoxi/Quinzeun/Brignol_OPC.pdf
- << Précédent